Moreover, HMGCR upregulates PD-1 expression in Tregs via the p38 MAPK/GSK3β axis, thereby enhancing Tregs’ suppression of antitumor immunity and supporting tumor progression (34). The gene discussed is PDCD1; the disease is neoplasm.